Davol Acquires XenMatrix from Brennen Medical: A Move to Capture Future Growth Opportunities - Deal Analysis From GlobalData
Davol Acquires XenMatrix from Brennen Medical: A Move to Capture Future Growth Opportunities - Deal Analysis From GlobalData
Summary
GlobalData’s report, “Davol Acquires XenMatrix from Brennen: A Move to Capture Future Growth Opportunities” provides key information and analysis on Davol Inc’ acquisition of XenMatrix, a non-crosslinked porcine xenograft from Brennen Medical. The report discusses the specifics of the deal agreement and transfer of related assets. The report provides information on the global incidence of hernia and the regenerative medicine market and the current and forecast market for the same. The report mentions the revenues for hernia repair and breast reconstruction for 2009 and a forecast of 2014 is provided.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
Reasons to buy
Summary
GlobalData’s report, “Davol Acquires XenMatrix from Brennen: A Move to Capture Future Growth Opportunities” provides key information and analysis on Davol Inc’ acquisition of XenMatrix, a non-crosslinked porcine xenograft from Brennen Medical. The report discusses the specifics of the deal agreement and transfer of related assets. The report provides information on the global incidence of hernia and the regenerative medicine market and the current and forecast market for the same. The report mentions the revenues for hernia repair and breast reconstruction for 2009 and a forecast of 2014 is provided.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Global regenerative medicine market in 2009 and forecast of 2014.
- Qualitative analysis on Davol’s acquisition of XenMatrix.
- Prevalence of Hernia in US.
- Global hernia repair procedure numbers.
- Breast reconstruction procedure number in the US.
- The Market penetration of Biologics in the regenerative medicine market.
Reasons to buy
- Develop business strategies by understanding the trends and developments which drive the penetration of biologics in the regenerative medicine market.
- Design and develop your marketing and sales strategies
- Develop market expansion strategies
- Exploit M&A opportunities by identifying key areas of growth
- Make more informed business decisions from the insightful and in-depth analysis of the global regenerative medicine market
Contents
1 TABLE OF CONTENTS1.1 List of Tables
2 DAVOL INC. ACQUIRES XENMATRIX FROM BRENNEN MEDICAL: A MOVE TO CAPTURE FUTURE GROWTH OPPORTUNITIES
2.1 Deal Summary
2.2 Deal Rationale
2.2.1 The Acquisition Strengthens Davol’s Abdominal Wall Repair Devices Product Portfolio
2.2.2 The Acquisition Allows Davol to Increase its Focus on Regenerative Medicine for Abdominal Wall Repair and Breast Reconstruction Market
2.3 Conclusion
2.4 Company Profiles
3 APPENDIX
3.1 Methodology
3.1.1 Coverage
3.1.2 Secondary Research
3.1.3 Primary Research
3.1.4 Expert Panel Validation
3.2 Contact Us
3.3 Disclaimer
LIST OF TABLES
Table 1: Davol Inc., Company Profile
Table 2: Brennen Medical, LLC., Company Profile Skip to top